Volker Wiebking

9PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsReaction engineering (excl. nuclear reactions)Prosthetics and orthoticsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 03, 2025
Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery.

Amanda X Y Chen, Kah Min Yap, Joelle S Kim

|Nov 13, 2024
TET2 regulates early and late transitions in exhausted CD8+ T cell differentiation and limits CAR T cell function.

Alexander J Dimitri, Amy E Baxter, Gregory M Chen

|Jun 28, 2022
Reengineering Ponatinib to Minimize Cardiovascular Toxicity.

Anna P Hnatiuk, Arne A N Bruyneel, Dhanir Tailor

|Jul 15, 2020
Metabolic engineering generates a transgene-free safety switch for cell therapy.

Volker Wiebking, James O Patterson, Renata Martin

|Mar 21, 2020
Tuning the Antigen Density Requirement for CAR T-cell Activity.

Robbie G Majzner, Skyler P Rietberg, Elena Sotillo

|Dec 05, 2019
Author Correction: Gene correction for SCID-X1 in long-term hematopoietic stem cells.

Mara Pavel-Dinu, Volker Wiebking, Beruh T Dejene

Pageof 2